Diamond Publications - Search Results

Search Again...

These results only include publications that have been reviewed and processed by Diamond Light Source. To also view papers that have not yet been processed click here.

You can use the folder icon under Actions to collate papers as required. You can then click on View Folder in the left-hand navigation to review and/or download your folder.

One item found (0 items not approved).

Instruments / Technical Area	Publication Details	Published	Actions
I04-1-Macromolecular Crystallography (fixed wavelength)	Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA Christopher J. Holland , Rory M. Crean , Johanne M. Pentier , Ben De Wet , Angharad Lloyd , Velupillai Srikannathasan , Nikolai Lissin , Katy A. Lloyd , Thomas H. Blicher , Paul J. Conroy , Miriam Hock , Robert J. Pengelly , Thomas E. Spinner , Brian Cameron , Elizabeth A. Potter , Anitha Jeyanthan , Peter E. Molloy , Malkit Sami , Milos Aleksic , Nathaniel Liddy , Ross A. Robinson , Stephen Harper , Marco Lepore , Chris R. Pudney , Marc W. Van Der Kamp , Pierre J. Rizkallah , Bent K. Jakobsen , Annelise Vuidepot , David K. Cole Journal Of Clinical Investigation 130, 2673 - 2688 DOI: 10.1172/JCI130562 Diamond Proposal Number(s): [17077, 14843] Show Abstract ▼ Abstract: Tumor-associated peptide–human leukocyte antigen complexes (pHLAs) represent the largest pool of cell surface–expressed cancer-specific epitopes, making them attractive targets for cancer therapies. Soluble bispecific molecules that incorporate an anti-CD3 effector function are being developed to redirect T cells against these targets using 2 different approaches. The first achieves pHLA recognition via affinity-enhanced versions of natural TCRs (e.g., immune-mobilizing monoclonal T cell receptors against cancer [ImmTAC] molecules), whereas the second harnesses an antibody-based format (TCR-mimic antibodies). For both classes of reagent, target specificity is vital, considering the vast universe of potential pHLA molecules that can be presented on healthy cells. Here, we made use of structural, biochemical, and computational approaches to investigate the molecular rules underpinning the reactivity patterns of pHLA-targeting bispecifics. We demonstrate that affinity-enhanced TCRs engage pHLA using a comparatively broad and balanced energetic footprint, with interactions distributed over several HLA and peptide side chains. As ImmTAC molecules, these TCRs also retained a greater degree of pHLA selectivity, with less off-target activity in cellular assays. Conversely, TCR-mimic antibodies tended to exhibit binding modes focused more toward hot spots on the HLA surface and exhibited a greater degree of crossreactivity. Our findings extend our understanding of the basic principles that underpin pHLA selectivity and exemplify a number of molecular approaches that can be used to probe the specificity of pHLA-targeting molecules, aiding the development of future reagents.	Apr 2020

Instruments / Technical Area

Publication Details

Published

Actions

I04-1-Macromolecular Crystallography (fixed wavelength)

Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA